Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

More PDE4 inhibitors described by Byk Gulden

Aug. 20, 1998

TA-270 inhibits the immediate and late asthmatic response and blocks DTH in animal studies

Aug. 19, 1998

SynPhar's HLE inhibitors show unique potential in preventing lung injury

Aug. 18, 1998

Two new series of PDE4 inhibitors reported by Byk Gulden

Aug. 18, 1998

Schering-Plough patents new tachykinin NK1/NK2 antagonists

Aug. 14, 1998

More PDE IVA inhibitors in the pipeline at Kyowa Hakko

Aug. 13, 1998

Menarini's NK1 antagonist MEN-11467 shows promising antiasthmatic activity

Aug. 12, 1998

Antiinflammatory cytokine modulators described by Amgen

Aug. 12, 1998

Kyowa Hakko discovers PDE IVA inhibitors for a range of potential indications

Aug. 12, 1998

RS-601, a dual-action TxA2/LTD4 antagonist with potent antiasthmatic effects

Aug. 11, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 6, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...